1 Min Read
Oct 3 (Reuters) - Biomarin Pharmaceutical Inc
* Biomarin Pharmaceutical says on September 28, 2017, board of directors of increased size of board from nine to ten members - SEC filing Source: (bit.ly/2yWOHiP) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.